Vinmec performs its first total femoral replacement for world's youngest cancer patient
HANOI, VIETNAM - Media OutReach Newswire - 11 June 2025 - Vinmec Healthcare System has successfully performed a Total Femoral Replacement (TFR) surgery using personalized 3D printing materials for the world's youngest cancer patient. It is also the first biomedical product designed and produced entirely in Vietnam, marking a major milestone in the country's advancement in precision medicine.
Refusing to Surrender to Fate
In October 2022, after a minor fall, Tran Minh Duc (a boy from Ho Chi Minh City) hurt his left thigh. Believing it to be just a simple injury, his family was shocked to hear the bad news from the doctor: The boy was diagnosed with osteosarcoma - a malignant bone cancer with a tumor that had invaded his entire femur. It is typically seen in adolescents, but rare and haphazard in younger children.
Given the severe prognosis, most medical facilities recommended amputation to ensure his survival or bone grafting (a conventional method). Both methods carry a high risk of rejection and infection, especially for younger children in the development stage.
The flash of hope appeared when she met Prof. Dr. Tran Trung Dung - Director of the Orthopedic Council, Vinmec Healthcare System. An unprecedented approach was proposed to apply to such a young patient: replacing the entire femur with personalized 3D-printed materials that are produced in Vietnam.
A 'Legendary' Surgery with Vietnamese Technologies
According to Prof. Dr. Tran Trung Dung, the entire femur of Duc has been invaded by the tumor. To ensure his life, Duc's leg had to be amputated. However, different types of artificial joints available on the market are not compatible with young bodies.
After various interdisciplinary case conferences including Orthopedics, Oncology, Diagnostic Imaging, Pathology, Clinical Pharmacy, etc., the Vinmec experts reached a consensus on the optimal approach - a two-phase surgery. Phase 1 (January 2024): Removing the tumor and temporarily grafting a cement bone. Phase 2 (May 2025): Replacing the entire femur with a 'customized' bone made of 3D-printed metal.
On January 29, 2024, Duc underwent his first surgery - removing the entire tumor and temporarily grafting a cement bone. In May 2025 when his conditions had stabilized, Duc's entire femur was replaced with a 'customized' bone made of 3D-printed metal. For the first time, 3D printing was applied to the youngest patient in the world with the collaboration between Vinmec medical professionals and VinUni's engineers. The bone's design is modular, enabling future extensions based on the child's physical development.
According to MSc. Dr. Tran Duc Thanh, who was directly engaged in the surgery: 'We contacted foreign manufacturers but there was no suitable design. Self-manufacturing the equipment allows us to be proactive in treatment, it also paves the way for a new direction for Vietnamese medicine.'
Prof. Dr. Tran Trung Dung added: 'The 4-hour surgery was a success. Duc recovered quickly without any complications, now he is able to walk with the support of physical therapy. The surgery represented a breakthrough in complex techniques and the evidence for sound collaboration in the multidisciplinary medical team. Both the life and limb of the child were kept intact.'
Vinmec - Pioneering in Vietnam's Personalized Precision Medicine
Once at risk of amputation and life-long dependence, Minh Duc is now able to walk on his own feet, supported by physical therapy without any complications of infection or transplant rejection. Every step Duc takes is a testament to precision medicine, advanced technologies, and the unwavering love of his mother.
'When my son stood up, I was trembling with joy. He has been unable to walk for nearly two years. Now he did it. I just hope that he will be capable of riding a bike and playing football like his peers...' - Ms. Hoang said in tears.
Prof. Dr. Tran Trung Dung also shared his emotions: 'We believe that modern medicine and compassion should go side by side. Duc is not just a special patient, his case represents a story of determination, maternal love, and the faith that the impossible can become possible if we never give up.'
Vinmec is the first Vietnamese healthcare system that applies personalized 3D printing in the treatment of musculoskeletal conditions. Instead of using standardized equipment, Vinmec uses CT and MRI data in the design of artificial joints and bones tailored to each patient to optimize motor functions, enhance precision, and reduce the recovery period.
To date, Vinmec has achieved successes in many difficult and rare cases, e.g. liver transplantation for an 8-month-old patient from a brain-dead donor, the first in Southeast Asia to reproduce 3D-printed titanium chest wall, and the first in the world to replace the pelvis and femur at the same time with 3D-printed bones.
With its series of breakthroughs and pioneering achievements in high-tech healthcare and precision medicine, Vinmec further affirms the aspiration to elevate the position of Vietnam in the global medical field.
Vinmec - A Place of Healing and Reimagining the Future.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
a day ago
- The Sun
Prudential plc CEO Expresses Strategic Commitment to India in Meeting with Union Finance Minister Nirmala Sitharaman
NEW DELHI, INDIA - Media OutReach Newswire - 20 June 2025 - Prudential plc ('Prudential') Chief Executive Officer, Anil Wadhwani, met yesterday with Smt. Nirmala Sitharaman, Union Minister for Finance and Corporate Affairs, Government of India, emphasising India's strategic importance to the UK FTSE100 insurer and asset manager operating across Asia and Africa. Prudential provides life insurance solutions in India through ICICI Prudential Life Insurance Company Limited, a preeminent life insurer and the first private insurance company listed in India. It also has a market-leading asset management presence via a separate joint venture with ICICI Bank, ICICI Prudential Asset Management Co. Ltd. Earlier this year, Prudential announced plans to establish a standalone health insurance joint venture with Vama Sundari Investments (Delhi) Private Limited, a promoter company of the HCL Group. During the meeting, Mr. Anil Wadhwani remarked: 'We are deeply proud of our heritage in India, which began with our first branch in Kolkata in 1923. India is a core strategic market for Prudential. As the country advances towards its vision of 'Insurance for All' and continues to address the challenge of underinsurance, we see significant opportunities to bring our global expertise in protection, savings, and health solutions to serve the evolving needs of Indian consumers. Our long-standing connection with India, including our sponsorship of the historic 1983 Cricket World Cup, India's first World Cup victory, reflects our commitment to its growth and aspirations.' Highlighting health as a shared strategic priority, Mr. Wadhwani conveyed the company's commitment to leveraging its global expertise and technology to help Indian consumers access affordable and quality healthcare coverage. This aligns with the Government of India's vision of 'Insurance for All by 2047'. India is not only a key strategic insurance market but also an incredible source of talent. Prudential recently launched a Global Capability Centre in Bengaluru. This strategic hub serves as a global centre for technology, AI, data analytics, cybersecurity, and innovation. Concluding the meeting, Mr. Wadhwani said: 'India's economic progress over the past decade has been remarkable. With sustained capital investment in infrastructure and proactive government economic measures to stimulate growth, we remain excited about India's long term growth prospects. We look forward to continuing our constructive collaboration with the Indian government to support its development goals and to build enduring insurance and technology businesses.' During the visit, Mr. Wadhwani also met with senior officials from the Department for Promotion of Industry and Internal Trade (DPIIT) and the Prime Minister's Office.
The Sun
2 days ago
- The Sun
Hong Kong Baptist University Showcases World-Leading Research in Digital Health & Systems Medicine at THE Global Sustainable Development Congress 2025
ISTANBUL, TURKEY - Media OutReach Newswire - 19 June 2025 – Hong Kong Baptist University (HKBU) illuminated the path to global well-being as the Global Health Innovation Partner and sponsor of the Health and Wellbeing Track at the Times Higher Education (THE) Global Sustainable Development Congress (GSDC) 2025, from June 16-19, 2025. At this gathering of over 5,000 global thought leaders, HKBU presented its comprehensive, interdisciplinary strategy for health and well-being, spearheaded by its Health & Drug Discovery research cluster. Firmly aligned with the United Nations' Sustainable Development Goals, HKBU's vision for health transformation drives from data to actionable insight. It comprehensively integrates mental and digital well-being, real-time analytics, and innovative interdisciplinary approaches. This includes blending traditional Chinese Medicine with cutting-edge sciences like chemical biology and data analytics, complemented by advancements in environmental, physical, and social sciences. A Hub for Holistic Health A highlight of HKBU's presence was the 6,000-square-foot 'Well-being Zone', thoughtfully designed to embody the principle that health is holistic and interconnected. This innovative Zone brought the concept of interdisciplinarity to a global audience by seamlessly integrating diverse fields, from martial arts and mindfulness to cutting-edge digital health monitoring: • Interdisciplinary Movement & Mindfulness: Tai Chi, Baduanjin and Mindfulness Karate sessions demonstrated HKBU's 'exercise is medicine' philosophy. • Real-Time Digital Well-being Research: Participants had the unique opportunity to contribute live data for Professor Christy Cheung's pioneering studies, which explore how digital tools can effectively measure mindfulness and enhance overall well-being. • Expert-Led Talks: Distinguished HKBU academics presented cutting-edge interdisciplinary research. Topics included critical global health trends, advancements in mental well-being, and innovative applications of Chinese Medicine and AI in modern healthcare. • Reflection & Rejuvenation Spaces: Thoughtfully curated 'chill-out' relaxation areas, massage corners and a juice bar provided spaces for participants to experience a reboot of the body and the mind. Highlighting HKBU's research strength in the transformative power of technology for global health, Professor Martin Wong, Provost & Chair Professor of Computer Science, emphasised, 'HKBU's recent top-50 global ranking in databases, design automation, and artificial intelligence underscores our collaborative ethos. By integrating advanced AI methodologies with clinical, pharmaceutical and social-science expertise, we are optimising diagnostics, accelerating drug discovery and enhancing surgical assistance. This interdisciplinary approach reinforces Hong Kong's reputation as a global hub for cutting-edge research and higher education.' Professor Lyu Aiping, Vice-President (Research & Development), highlighted HKBU's strategic edge, 'Hong Kong is uniquely positioned to lead East–West integration in digital health and systems medicine. HKBU combines the rigour of life sciences with robust Chinese Medicine research, underpinned by advanced data analytics. This powerful synergy enables us to tackle complex health disparities at biological, social, and environmental levels, and build resilient, equitable health systems to meet future global challenges.' In addition to numerous insightful presentations and the interactive experiences, HKBU Provost Professor Martin Wong gave a keynote at the session entitled 'Reframing Sustainability through the Lens of Chinese Heritage and Innovation' convened by the China Education Association for International Exchange. HKBU also released the 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine' Report ( in collaboration with Elsevier. This report examines the development and evolving research landscape of Chinese Medicine and its growing influence on modern healthcare.
The Sun
3 days ago
- The Sun
Hong Kong Baptist University and Elsevier Report Highlights Global Expansion of Chinese Medicine Research, Urges Standardised Frameworks for Broader Integration
ISTANBUL, TURKEY - Media OutReach Newswire - 18 June 2025 – The report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine' released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, 'Chinese Medicine research' encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field's rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine. Key findings from the report include: · Rapid expansion: Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. · High scholarly impact: 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. · Interdisciplinary breadth: Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. · Global collaboration hubs: Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. · Emerging research foci: Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. · Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest. Bridging a global integration gap Chinese Medicine's mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact. ''Evolving Legacy' demonstrates how Chinese Medicine research has matured into a global, evidence-informed field,' said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine. 'We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.' 'This report offers unprecedented insights into Chinese Medicine's evolving scientific landscape,' added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. 'It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health.' The report was developed using Elsevier's bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on
